We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AARP Urges Approval of Follow-On Biologics Bill
AARP Urges Approval of Follow-On Biologics Bill
April 6, 2007
Faced with soaring healthcare costs driven in part by biopharmaceutical therapies, federal policymakers should give the FDA power to approve follow-on biologics, AARP said.